Nebi Serkan Demirci

7PUBLICATIONS
20CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 06, 2026
Immune-Mediated upper gastrointestinal toxicities reported With immune checkpoint inhibitors: An analysis of the food and drug administration adverse event reporting system (FAERS).

|Apr 21, 2026
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab.

|Dec 30, 2025
Stage II colon cancer: does ChatGPT recommend more intensive adjuvant therapy? A comparison with MDT decisions.

Zeliha Birsin, Seda Jeral, Selin Cebeci

|May 18, 2024
Prognostic factors in Kaposi sarcoma, single centre experience.

Ezgi Değerli, Kerem Oruç, Nihan Şentürk Öztaş

|Dec 08, 2021
Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme.

Ezgi Değerli, Gülin Alkan, Nihan Şentürk Öztaş

|Mar 08, 2021
Use of volumetric CT scanning to predict tumor staging and survival in pancreatic cancer patients that are to be administered curative resection.

Nilay Sengul Samanci, Emir Çelik, Omer Bagcilar

Pageof 2

Frequent Collaborators

3 joint publications

Nihan Senturk Oztas

2 joint publications

Murat Günaltılı

2 joint publications

Nilay Sengul Samanci

2 joint publications

Ezgi Değerli